These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3900946)

  • 21. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime.
    Heusser MF; Patterson JE; Kuritza AP; Edberg SC; Baltimore RS
    Pediatr Infect Dis J; 1990 Jul; 9(7):509-12. PubMed ID: 2371083
    [No Abstract]   [Full Text] [Related]  

  • 22. Unusual presentation of primary klebsiella meningitis: successful treatment with cefotaxime.
    Sandyk R; Brennan MJ
    Postgrad Med J; 1983 Apr; 59(690):256-7. PubMed ID: 6306628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.
    Scheld WM; Fink FN; Fletcher DD; Sande MA
    Antimicrob Agents Chemother; 1979 Sep; 16(3):271-6. PubMed ID: 228591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of purulent meningitis in the child using Cefotaxime].
    Borderon JC; Despert F; Santini JJ; Laugier J
    Pediatrie; 1985 Jun; 40(4):291-9. PubMed ID: 3909093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Shah PM; Armengaud M; Barza M; Cherubin CE
    Am J Med; 1981 Oct; 71(4):693-703. PubMed ID: 6269429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.
    Bryan CS; John JF; Pai MS; Austin TL
    Am J Dis Child; 1985 Nov; 139(11):1086-9. PubMed ID: 3904403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.
    Täuber MG; Shibl AM; Hackbarth CJ; Larrick JW; Sande MA
    J Infect Dis; 1987 Sep; 156(3):456-62. PubMed ID: 3302052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cefotaxime CSF levels in children with purulent meningitis (author's transl)].
    Borderon JC; Prieur D; Huguet B
    Nouv Presse Med; 1981 Feb; 10(8):580-4. PubMed ID: 6259596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cephalosporin compounds in severe neonatal infection.
    Schaad UB
    Eur J Pediatr; 1984 Jan; 141(3):143-6. PubMed ID: 6321189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of bacterial meningitis with ceftizoxime.
    Overturf GD; Cable DC; Forthal DN; Shikuma C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):258-62. PubMed ID: 6324670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterobacter meningitis--treatment complicated by emergence of mutants resistant to cefotaxime.
    Ralph ED; Behme RJ
    Scand J Infect Dis; 1987; 19(5):577-9. PubMed ID: 3423747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of Enterobacter in neonatal sepsis: a twenty-two-year study.
    Hervas JA; Ballesteros F; Alomar A; Gil J; Benedi VJ; Alberti S
    Pediatr Infect Dis J; 2001 Feb; 20(2):134-40. PubMed ID: 11224829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment with a cefotaxime-fosfomycin combination of staphylococcal or enterobacterial meningitis in adults].
    Portier H; Armengaud M; Becq-Giraudon B; Bousser J; Desbordes JM; Duez JM; Kazmierczak A; Korinek AM; Laisne MJ; Pangon B
    Presse Med; 1987 Dec; 16(43):2161-6. PubMed ID: 2963304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.
    Eng RH; Cherubin CE; Pechere JC; Beam TR
    J Antimicrob Chemother; 1987 Dec; 20(6):903-11. PubMed ID: 3501999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital-acquired neonatal bacterial meningitis: the impacts of cefotaxime usage on mortality and of amikacin usage on incidence.
    Coovadia YM; Mayosi B; Adhikari M; Solwa Z; van den Ende J
    Ann Trop Paediatr; 1989 Dec; 9(4):233-9. PubMed ID: 2482005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the use of cefotaxime for pediatric meningitis in Portugal.
    Lecour H; Miranda AM; Nogueira JA; Abreu C
    Diagn Microbiol Infect Dis; 1995; 22(1-2):125-7. PubMed ID: 7587025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.